Galmed Pharmaceuticals Ltd. buy StockNews.com
Start price
11.03.23
/
50%
€0.42
Target price
11.03.24
-
Performance (%)
-21.70%
End price
12.03.24
€0.33
Summary
This prediction ended on 12.03.24 with a price of €0.33. The prediction for Galmed Pharmaceuticals Ltd. disappointed with a performance of -21.70%. StockNews_com has a follow-up prediction for Galmed Pharmaceuticals Ltd. where he still thinks Galmed Pharmaceuticals Ltd. is a Buy. StockNews_com has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Galmed Pharmaceuticals Ltd. | - | - | - | - |
| iShares Core DAX® | -2,49 % | 0,32 % | 0,75 % | 51,02 % |
| iShares Nasdaq 100 | -4,40 % | 1,59 % | 32,09 % | 87,97 % |
| iShares Nikkei 225® | -4,29 % | 0,97 % | 50,00 % | 61,27 % |
| iShares S&P 500 | -2,20 % | 2,00 % | 22,60 % | 65,12 % |
Comments by StockNews_com for this prediction
In the thread Galmed Pharmaceuticals Ltd. diskutieren
Globus Medical, Inc. (NYSE: GMED) was upgraded by analysts at StockNews.com from a "hold" rating to a "buy" rating.
Ratings data for GMED provided by MarketBeat
In the thread Trading Galmed Pharmaceuticals Ltd.
Die von StockNews_com gewählte maximale Laufzeit wurde überschritten